Lipella Pharmaceuticals Inc. (LIPO): Total Assets

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

$2.67M
As of 2024-12-31
$2.35M
As of 2025-09-30
+9.9%
3-year compound annual growth
$5.95M2021-12-31: $2.01M2022-12-31: $5.95M2023-12-31: $3.58M2024-12-31: $2.67M$2.67M
2021-12-31 Total Assets (USD) 2024-12-31
Period endedTotal AssetsChange YoYSource filing
2024-12-31$2.67M-25.3%2025-03-28, Balance as of period end
2023-12-31$3.58M-39.9%2025-03-28, Balance as of period end
2022-12-31$5.95M+195.6%2024-02-27, Balance as of period end
2021-12-31$2.01Mn/a2023-03-31, Balance as of period end